Nov 17, 2021 / 10:30PM GMT
Presentation (Japanese)
Nov 17, 2021 / 10:30PM GMT
=====================
Corporate Participants
=====================
* Adrian Murphy
Shire plc - Senior VP & Head of Plasma Operations
* Dana Mendenhall
* Elizabeth Borgeson
Takeda Pharmaceutical Company Limited - Executive of IR
* Hema Tallman
* Julie Kim
Takeda Pharmaceutical Company Limited - President of Plasma-Derived Therapies Business Unit
* Kristina Allikmets
* Ramy Riad
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Andrew Goodsall
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc. Exchange Research - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
* Shinichiro Muraoka
Takeda Pharmaceutical Co Ltd
(BSP:TAKP34)
R$
92.25
+2.27 (+2.52%)
Market Cap: 294.60 Bil
Enterprise Value: 439.28 Bil
PE Ratio: 0
PB Ratio: 1.17
GF Score: 59/100 Takeda Pharmaceutical Co Ltd Plasma-Derived Therapies Investor Event Presentation (Japanese) Transcript
Nov 17, 2021 / 10:30PM GMT
Release Date Price:
R$77.96
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot